1. Home
  2. COCP vs SOS Comparison

COCP vs SOS Comparison

Compare COCP & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • SOS
  • Stock Information
  • Founded
  • COCP 2006
  • SOS 2004
  • Country
  • COCP United States
  • SOS China
  • Employees
  • COCP N/A
  • SOS N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • SOS Finance: Consumer Services
  • Sector
  • COCP Health Care
  • SOS Finance
  • Exchange
  • COCP Nasdaq
  • SOS Nasdaq
  • Market Cap
  • COCP 15.4M
  • SOS 14.8M
  • IPO Year
  • COCP N/A
  • SOS 2017
  • Fundamental
  • Price
  • COCP $1.45
  • SOS $5.78
  • Analyst Decision
  • COCP Strong Buy
  • SOS
  • Analyst Count
  • COCP 1
  • SOS 0
  • Target Price
  • COCP $7.00
  • SOS N/A
  • AVG Volume (30 Days)
  • COCP 15.8K
  • SOS 21.6K
  • Earning Date
  • COCP 05-27-2025
  • SOS 01-01-0001
  • Dividend Yield
  • COCP N/A
  • SOS N/A
  • EPS Growth
  • COCP N/A
  • SOS N/A
  • EPS
  • COCP N/A
  • SOS N/A
  • Revenue
  • COCP N/A
  • SOS $111,124,000.00
  • Revenue This Year
  • COCP N/A
  • SOS N/A
  • Revenue Next Year
  • COCP N/A
  • SOS N/A
  • P/E Ratio
  • COCP N/A
  • SOS N/A
  • Revenue Growth
  • COCP N/A
  • SOS N/A
  • 52 Week Low
  • COCP $1.12
  • SOS $4.04
  • 52 Week High
  • COCP $3.26
  • SOS $19.05
  • Technical
  • Relative Strength Index (RSI)
  • COCP 52.12
  • SOS 56.58
  • Support Level
  • COCP $1.46
  • SOS $4.48
  • Resistance Level
  • COCP $1.79
  • SOS $7.51
  • Average True Range (ATR)
  • COCP 0.16
  • SOS 0.46
  • MACD
  • COCP 0.00
  • SOS 0.17
  • Stochastic Oscillator
  • COCP 40.00
  • SOS 38.94

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: